Cargando…

Acute Myeloid Leukemia Stem Cells: The Challenges of Phenotypic Heterogeneity

SIMPLE SUMMARY: Relapse after apparent remission remains a major cause of death in patients with acute myeloid leukemia (AML). On the cellular level, leukemia relapse is considered to emerge from subpopulations of therapy-resistant leukemic stem cells (LSC). Identification and targeting of LSC are t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Arnone, Marlon, Konantz, Martina, Hanns, Pauline, Paczulla Stanger, Anna M., Bertels, Sarah, Godavarthy, Parimala Sonika, Christopeit, Maximilian, Lengerke, Claudia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7764578/ https://www.ncbi.nlm.nih.gov/pubmed/33322769 http://dx.doi.org/10.3390/cancers12123742

Ejemplares similares

Stress and catecholamines modulate the bone marrow microenvironment to promote tumorigenesis
por: Hanns, Pauline, et al.
Publicado: (2019)

P462: RECIPIENT SEX AND DONOR RISK GROUP INFLUENCE LEUKEMIA KINETICS IN NSG MICE
por: Arnone, Marlon, et al.
Publicado: (2023)

The Laminin Receptors Basal Cell Adhesion Molecule/Lutheran and Integrin α7β1 on Human Hematopoietic Stem Cells
por: Godavarthy, Parimala Sonika, et al.
Publicado: (2021)

Long-term observation reveals high-frequency engraftment of human acute myeloid leukemia in immunodeficient mice
por: Paczulla, Anna M., et al.
Publicado: (2017)

Modeling hematopoietic disorders in zebrafish
por: Konantz, Martina, et al.
Publicado: (2019)

Novel therapeutic options in Acute Myeloid Leukemia
por: Medinger, Michael, et al.
Publicado: (2016)

Molecular and functional interactions between AKT and SOX2 in breast carcinoma
por: Schaefer, Thorsten, et al.
Publicado: (2015)

The vascular bone marrow niche influences outcome in chronic myeloid leukemia via the E-selectin - SCL/TAL1 - CD44 axis
por: Godavarthy, Parimala Sonika, et al.
Publicado: (2020)

The differential role of the lipid raft-associated protein flotillin 2 for progression of myeloid leukemia
por: Kumar, Rahul, et al.
Publicado: (2022)

Bone marrow niche-derived extracellular matrix-degrading enzymes influence the progression of B-cell acute lymphoblastic leukemia
por: Verma, Divij, et al.
Publicado: (2020)

Genetic, Phenotypic, and Clinical Heterogeneity of NPM1-Mutant Acute Myeloid Leukemias
por: Testa, Ugo, et al.
Publicado: (2023)

TKI Maintenance After Stem-Cell Transplantation for FLT3-ITD Positive Acute Myeloid Leukemia: A Systematic Review and Meta-Analysis
por: Gagelmann, Nico, et al.
Publicado: (2021)

Mutation order in acute myeloid leukemia identifies uncommon patterns of evolution and illuminates phenotypic heterogeneity
por: Majeti, Ravi, et al.
Publicado: (2023)

PB1849: EARLY SALVAGE THERAPY WITH VENETOCLAX AND 10-DAY DECITABINE IS FEASIBLE AND SAFE IN REFRACTORY AML: RESULTS FROM 11 PATIENTS WITH EARLY INDUCTION FAILURE
por: Borst, Carla, et al.
Publicado: (2023)

Demethylator phenotypes in acute myeloid leukemia
por: Kelly, Andrew D., et al.
Publicado: (2018)

ABR, a novel inducer of transcription factor C/EBPα, contributes to myeloid differentiation and is a favorable prognostic factor in acute myeloid leukemia
por: Namasu, Carolina Yaeko, et al.
Publicado: (2017)

Diagnostic challenge in mixed phenotype acute leukemia with T/megakaryocyte or T/myeloid lineages accompanied by t(3;3)
por: Jia, Yannan, et al.
Publicado: (2022)

Epigenetic Modifications in Acute Myeloid Leukemia: Prognosis, Treatment, and Heterogeneity
por: Goldman, Samantha L., et al.
Publicado: (2019)

Azacitidine, lenalidomide and donor lymphocyte infusions for relapse of myelodysplastic syndrome, acute myeloid leukemia and chronic myelomonocytic leukemia after allogeneic transplant: the Azalena-Trial
por: Schroeder, Thomas, et al.
Publicado: (2023)

Mixed-phenotypic acute leukemia: cytochemically myeloid and phenotypically early T-cell precursor acute lymphoblastic leukemia
por: Gajendra, Smeeta, et al.
Publicado: (2014)

Heterogeneity of BCR-ABL rearrangement in patients with chronic myeloid leukemia in Pakistan
por: Tabassum, Najia, et al.
Publicado: (2014)

Distinct evolution and dynamics of epigenetic and genetic heterogeneity in acute myeloid leukemia
por: Li, Sheng, et al.
Publicado: (2016)

Targeting Cellular Metabolism in Acute Myeloid Leukemia and the Role of Patient Heterogeneity
por: Grønningsæter, Ida Sofie, et al.
Publicado: (2020)

DNA Methylation and Intra-Clonal Heterogeneity: The Chronic Myeloid Leukemia Model
por: Lebecque, Benjamin, et al.
Publicado: (2021)

HardwareSoftware Co-design for Heterogeneous Multi-core Platforms: The hArtes Toolchain
por: Bertels, Koen
Publicado: (2012)

Challenges in Treating Older Patients with Acute Myeloid Leukemia
por: Eleni, Lagadinou D., et al.
Publicado: (2010)

Molecular Mechanisms of Resistance to FLT3 Inhibitors in Acute Myeloid Leukemia: Ongoing Challenges and Future Treatments
por: Scholl, Sebastian, et al.
Publicado: (2020)

Heterogeneous sensitivity of human Acute Myeloid Leukemia to ß-catenin down-modulation
por: Gandillet, Arnaud, et al.
Publicado: (2011)

Tumor heterogeneity of acute myeloid leukemia: insights from single-cell sequencing
por: Chen, AiLi, et al.
Publicado: (2019)

Developments and challenges of FLT3 inhibitors in acute myeloid leukemia
por: Ge, Shuai-Shuai, et al.
Publicado: (2022)

Progress and Challenges in Survivorship After Acute Myeloid Leukemia in Adults
por: Granroth, Ginna, et al.
Publicado: (2022)

Intra‐heterogeneity in transcription and chemoresistant property of leukemia‐initiating cells in murine Setd2(−/−) acute myeloid leukemia
por: Song, Jiachun, et al.
Publicado: (2021)

Concurrent Onset of Chronic Lymphocytic Leukemia and Atypical Phenotype Acute Myeloid Leukemia Revealed by Autopsy
por: Kiso, Sayaka, et al.
Publicado: (2021)

Scabies crustosa in a recipient of an allogeneic stem cell transplantation
por: Christopeit, Maximilian, et al.
Publicado: (2020)

Eryptotic Phenotype in Chronic Myeloid Leukemia: Contribution of Neutrophilic Cathepsin G
por: Govekar, Rukmini, et al.
Publicado: (2012)

ADAMTS2 gene dysregulation in T/myeloid mixed phenotype acute leukemia
por: Tota, Giuseppina, et al.
Publicado: (2014)

Heterogeneity of Patient-Derived Acute Myeloid Leukemia Cells Subjected to SYK In Vitro Inhibition
por: Brattås, Marte Karen, et al.
Publicado: (2022)

Acute myeloid leukemia with myelodysplasia-related changes and blasts of the mixed T/myeloid phenotype: a case report
por: Sheng, Xian-Fu, et al.
Publicado: (2022)

Treatment of Acute Myeloid Leukemia in the Era of Genomics—Achievements and Persisting Challenges
por: Green, Steven D., et al.
Publicado: (2020)

Therapeutic Challenges in Chronic Myeloid Leukemia: A Case-Based Discussion
por: Perez, Ariel, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_u6vfdat3aocjo560q5kqcu63ut